Suppr超能文献

C3 调控异常是由于补体因子 H 缺乏,这在体内与甘露聚糖结合凝集素相关丝氨酸蛋白酶(MASP)-1 和 MASP-3 无关。

C3 dysregulation due to factor H deficiency is mannan-binding lectin-associated serine proteases (MASP)-1 and MASP-3 independent in vivo.

机构信息

Centre for Complement & Inflammation Research, Imperial College London, London, UK.

出版信息

Clin Exp Immunol. 2014 Apr;176(1):84-92. doi: 10.1111/cei.12244.

Abstract

Uncontrolled activation of the complement alternative pathway is associated with complement-mediated renal disease. Factor B and factor D are essential components of this pathway, while factor H (FH) is its major regulator. In complete FH deficiency, uncontrolled C3 activation through the alternative pathway results in plasma C3 depletion and complement-mediated renal disease. These are dependent on factor B. Mannan-binding lectin-associated serine proteases 1 and 3 (MASP-1, MASP-3) have been shown recently to contribute to alternative pathway activation by cleaving pro-factor D to its active form, factor D. We studied the contribution of MASP-1 and MASP-3 to uncontrolled alternative pathway activation in experimental complete FH deficiency. Co-deficiency of FH and MASP-1/MASP-3 did not ameliorate either the plasma C3 activation or glomerular C3 accumulation in FH-deficient mice. Our data indicate that MASP-1 and MASP-3 are not essential for alternative pathway activation in complete FH deficiency.

摘要

补体替代途径的失控激活与补体介导的肾脏疾病有关。因子 B 和因子 D 是该途径的必需成分,而因子 H(FH)是其主要调节剂。在完全 FH 缺乏症中,通过替代途径的不受控制的 C3 激活导致血浆 C3 耗竭和补体介导的肾脏疾病。这些依赖于因子 B。最近已经表明甘露聚糖结合凝集素相关丝氨酸蛋白酶 1 和 3(MASP-1、MASP-3)通过切割前因子 D 使其转化为活性形式因子 D 来促进替代途径的激活。我们研究了 MASP-1 和 MASP-3 在实验性完全 FH 缺乏症中对不受控制的替代途径激活的贡献。FH 和 MASP-1/MASP-3 的共同缺乏并不能改善 FH 缺乏小鼠的血浆 C3 激活或肾小球 C3 积聚。我们的数据表明,MASP-1 和 MASP-3 在完全 FH 缺乏症中不是替代途径激活所必需的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0060/3958157/65d9affce7ad/cei0176-0084-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验